CoChat

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.

Using failure mode and effects analysis to plan implementation of smart i.v. pump technology

Abstract

PURPOSE: Failure mode and effects analysis (FMEA) was used to evaluate a smart i.v. pump as it was implemented into a redesigned medication-use process. SUMMARY: A multidisciplinary team conducted a FMEA to guide the implementation of a smart i.v. pump that was designed to prevent pump programming errors. The smart i.v. pump was equipped with a dose-error reduction system that included a pre-defined drug library in which dosage limits were set for each medication. Monitoring for potential failures and errors occurred for three months postimplementation of FMEA. Specific measures were used to determine the success of the actions that were implemented as a result of the FMEA. The FMEA process at the hospital identified key failure modes in the medication process with the use of the old and new pumps, and actions were taken to avoid errors and adverse events. I.V. pump software and hardware design changes were also recommended. Thirteen of the 18 failure modes reported in practice after pump implementation had been identified by the team. A beneficial outcome of FMEA was the development of a multidisciplinary team that provided the infrastructure for safe technology implementation and effective event investigation after implementation. With the continual updating of i.v. pump software and hardware after implementation, FMEA can be an important starting place for safe technology choice and implementation and can produce site experts to follow technology and process changes over time. CONCLUSION: FMEA was useful in identifying potential problems in the medication-use process with the implementation of new smart i.v. pumps. Monitoring for system failures and errors after implementation remains necessary.

Overview

Integrity signals

Registry

Crossref · 10.2146/ajhp050515

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 35 references

Research works printed but not linked: 13

  1. 2002, Health Devices, 31, 353
  2. 2002, Biomed Instrum Technol, 36, 84
  3. 2002, Nurs Econ, 20, 80
  4. 2001, Jt Comm J Qual Improv, 27, 430
  5. 1994, Hosp Pharm, 29, 319
  6. 2004, Hosp Peer Rev, 29, 13
  7. 2002, J Am Pharm Assoc, 42, S54
  8. 2002, Jt Comm J Qual Improv, 28, 331
  9. 2004, Qual Saf Health Care, 13, 265, 10.1136/qshc.2003.007443 · doi:10.1136/qshc.2003.007443 · Paper page
  10. 2004, Clin Leadersh Manag Rev, 18, 37
  11. 2002, Jt Comm J Qual Improv, 28, 248
  12. 2004, Clin Leadersh Manag Rev, 18, 32
  13. 1998, PDA J Pharm Sci Technol, 52, 52

Cited by

See all 143

Metadata

Authors
Wetterneck, T. B., Skibinski, K. A., Roberts, T. L., Kleppin, S. M., Schroeder, M. E., Enloe, M., Rough, S. S., Hundt, A. S., & Carayon, P.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of Wisconsin Health (US)
  • Department of Anesthesiology, UWSMPH
  • UW Health University Hospital (US)
Corresponding author
Wetterneck, Tosha B.
Venue
American Journal of Health-System Pharmacy
Published
2006-08-15
Volume
63
Issue
16
Pages
1528-1538
ISSN
  • 1079-2082 (ISSN-L)
  • 1535-2900
OpenAlex
W1983207700
Cited by
134
References
35
Citations by year
2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 8 · 2019: 12 · 2018: 6 · 2017: 5 · 2016: 8 · 2015: 2 · 2014: 8 · 2013: 11 · 2012: 10
FWCI
2.18
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Health-System Pharmacy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Agency for Healthcare Research and Quality (1uc1hs014253-01)
  • National Center for Research Resources (1 K12-RR01764-01)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
  • Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
  • Health Sciences › Medicine › Surgery › Healthcare Technology and Patient Monitoring
Keywords
failure mode and effects analysis, smart infusion pumps, medication errors, drug library, patient safety, adverse event investigation, multidisciplinary team, technology implementation
MeSH terms
Equipment Safety, Humans, Infusion Pumps, Infusions, Intravenous, Reproducibility of Results, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Using failure mode and effects analysis to plan implementation of smart i.v. pump technology. https://app.cochat.ai/papers/10.2146/ajhp050515
The paper
Wetterneck, T. B., Skibinski, K. A., Roberts, T. L., Kleppin, S. M., Schroeder, M. E., Enloe, M., Rough, S. S., Hundt, A. S., & Carayon, P. (2006). Using failure mode and effects analysis to plan implementation of smart i.v. pump technology. American Journal of Health-System Pharmacy. https://doi.org/10.2146/ajhp050515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.